Schaarschmidt, Benedikt Michael
Grueneisen, Johannes
Stebner, Vanessa
Klode, Joachim
Stoffels, Ingo
Umutlu, Lale
Schadendorf, Dirk
Heusch, Philipp
Antoch, Gerald
Pöppel, Thorsten Dirk
Article History
Received: 22 January 2018
Accepted: 27 May 2018
First Online: 6 June 2018
Compliance with ethical standards
: Benedikt M. Schaarschmidt is a stockholder for Bayer AG, General Electric, Siemens AG, Siemencs Healthineers AG, TEVA Pharmaceuticals. All other authors declare that they have no conflict of interest. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.